Buclizine is a piperazine-class antihistamine with antiemetic and anti-vertigo properties, used for motion sickness and, in combination with analgesics, for migraine prophylaxis. Simson Pharma's Buclizine reference standard supports compendial testing for this legacy antihistamine combination product.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Buclizine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.